Haemonetics

Haemonetics

Yahoo Finance • 9 days ago

S&P at 8,000? Morgan Stanley says a post-election rally is coming

Investing.com and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Investing.com — The current equity correction is nearing its end, and a massive post-election relief rally is on the horizon. That i... Full story

Yahoo Finance • 16 days ago

Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50-Day Line

VANCOUVER, BC, Oct. 19, 2026 /PRNewswire/ -- Stock Preachers News Commentary - Big tech drove a sharp rebound into the close, with the Nasdaq Composite up 1.11% and the S&P 500 up 0.66% on the session, while the Dow Jones Industrial Averag... Full story

Yahoo Finance • 16 days ago

Haemonetics wins approval of PerQseal Elite vascular closure system

[FDA approved red rubber stamp] tang90246 * The US FDA approved Haemonetics' (HAE [https://seekingalpha.com/symbol/HAE]) PerQseal Elite vascular closure system, used in large-bore arterial procedures. * The system "provides sutureles... Full story

Yahoo Finance • 20 days ago

Stocks making the biggest moves premarket: Tesla, SpaceX, Alcoa, CoreWeave, Travelers & more

Check out the companies making the biggest moves premarket: Tesla — Shares climbed nearly 5% after the EV maker unveiled its long-awaited second-generation Roadster . The vehicle uses SpaceX-developed rocket-style thrusters and demonstrate... Full story

Yahoo Finance • 27 days ago

These healthcare stocks have the highest EPS revision grade ahead of Q3 results

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images As Q3 2026 earnings season approaches, healthcare stocks are drawing investor attention as markets assess earnings e... Full story

Yahoo Finance • 28 days ago

Stocks making the biggest moves premarket: Haemonetics, Broadcom, Lululemon, Wolfspeed & more

Check out the companies making the biggest moves premarket: Haemonetics — The blood and plasma provider popped 8% after CSL expects to complete the rollout of Haemonetics' plasmapheresis platform across the U.S. by the end of 2027. Wolfspe... Full story

Yahoo Finance • 2 months ago

Haemonetics upgraded to Buy at BofA on supply deal with CSL

[Wall Street sign in Lower Manhattan, NYC] georgeclerk Bank of America on Thursday upgraded Haemonetics (HAE [https://seekingalpha.com/symbol/HAE]) to Buy from Neutral, citing a recent supply deal the blood management solutions provider s... Full story

Yahoo Finance • 2 months ago

Lyft downgraded, Trip.com upgraded: Wall Street's top analyst calls

Lyft downgraded, Trip.com upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled b... Full story

Yahoo Finance • 2 months ago

GEHC vs. HAE: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Haemonetics (HAE). But which of these two stocks is more attractive to value investors? We'll need to take a closer... Full story

Yahoo Finance • 3 months ago

Haemonetics rises after supply deal with CSL

[Two coloured ropes knotted together] Richard Drury Shares of Haemonetics (HAE [https://seekingalpha.com/symbol/HAE]) added ~7% in the premarket on Tuesday after the blood management solutions provider disclosed a supply agreement with Au... Full story

Yahoo Finance • 3 months ago

Haemonetics (HAE) Q1 2027 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 8 a.m. ET CALL PARTICIPANTS Vice President, Investor Relations and Treasurer - Olga Guyette Chief Executive Officer - Christopher Simon Chief Financial Officer - James D'Are... Full story

Yahoo Finance • 3 months ago

Martin Madaus Elected to Haemonetics Board of Directors

BOSTON, July 28, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced today that Martin Madaus has been... Full story

Yahoo Finance • 3 months ago

3 Healthcare Stocks with Questionable Fundamentals

3 Healthcare Stocks with Questionable Fundamentals Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized strong financial performance, and o... Full story

Yahoo Finance • 4 months ago

3 Reasons HAE is Risky and 1 Stock to Buy Instead

3 Reasons HAE is Risky and 1 Stock to Buy Instead Over the last six months, Haemonetics's shares have sunk to $75.12, producing a disappointing 7.2% loss - a stark contrast to the S&P 500's 6.1% gain. This might have investors contemplati... Full story

Yahoo Finance • 5 months ago

Sector Update: Healthcare Stocks Higher Late Afternoon

Healthcare stocks rose late Friday afternoon with the NYSE Healthcare Index increasing 0.6% and the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 6 months ago

Haemonetics Q4 Earnings Call Highlights

Haemonetics logo Haemonetics (NYSE:HAE) reported fiscal fourth-quarter revenue of $346 million, up 5% on a reported basis and 9% organically excluding CSL, as strength in its Plasma and Blood Management Technologies businesses offset cont... Full story

Yahoo Finance • 6 months ago

Riverwater Sustainable Value Strategy Awaits Haemonetics Corporation’s (HAE) Market Validation

Riverwater Partners, an investment management company, released its “Sustainable Value Strategy” Q1 2026 investor letter. A copy of the letter can be downloaded here. In Q1 2026, the Riverwater Sustainable Value Strategy underperformed the... Full story

Yahoo Finance • 7 months ago

Is It Time To Reassess Haemonetics (HAE) After Prolonged Share Price Weakness

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. If you are wondering whether Haemonetics at around US$56.36 is starting to look attractively priced, the recent share... Full story

Yahoo Finance • 8 months ago

Does Haemonetics' (HAE) Hospital Rebound and NexSys Expansion Reframe Its Competitive Positioning?

In recent months, Haemonetics has reported a recovery in its Hospital division, supported by broader adoption of its FDA-approved NexSys PCS system with Persona Technology and the completed transition away from older PCS2 devices. This ope... Full story

Yahoo Finance • 8 months ago

2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have seen decent returns lately as healthcare stocks were up 3.8% over the past six month... Full story